Kaput Jim, Cotton Richard G H, Hardman Lauren, Watson Michael, Al Aqeel Aida I, Al-Aama Jumana Y, Al-Mulla Fahd, Alonso Santos, Aretz Stefan, Auerbach Arleen D, Bapat Bharati, Bernstein Inge T, Bhak Jong, Bleoo Stacey L, Blöcker Helmut, Brenner Steven E, Burn John, Bustamante Mariona, Calzone Rita, Cambon-Thomsen Anne, Cargill Michele, Carrera Paola, Cavedon Lawrence, Cho Yoon Shin, Chung Yeun-Jun, Claustres Mireille, Cutting Garry, Dalgleish Raymond, den Dunnen Johan T, Díaz Carlos, Dobrowolski Steven, dos Santos M Rosário N, Ekong Rosemary, Flanagan Simon B, Flicek Paul, Furukawa Yoichi, Genuardi Maurizio, Ghang Ho, Golubenko Maria V, Greenblatt Marc S, Hamosh Ada, Hancock John M, Hardison Ross, Harrison Terence M, Hoffmann Robert, Horaitis Rania, Howard Heather J, Barash Carol Isaacson, Izagirre Neskuts, Jung Jongsun, Kojima Toshio, Laradi Sandrine, Lee Yeon-Su, Lee Jong-Young, Gil-da-Silva-Lopes Vera L, Macrae Finlay A, Maglott Donna, Marafie Makia J, Marsh Steven G E, Matsubara Yoichi, Messiaen Ludwine M, Möslein Gabriela, Netea Mihai G, Norton Melissa L, Oefner Peter J, Oetting William S, O'Leary James C, de Ramirez Ana Maria Oller, Paalman Mark H, Parboosingh Jillian, Patrinos George P, Perozzi Giuditta, Phillips Ian R, Povey Sue, Prasad Suyash, Qi Ming, Quin David J, Ramesar Rajkumar S, Richards C Sue, Savige Judith, Scheible Dagmar G, Scott Rodney J, Seminara Daniela, Shephard Elizabeth A, Sijmons Rolf H, Smith Timothy D, Sobrido María-Jesús, Tanaka Toshihiro, Tavtigian Sean V, Taylor Graham R, Teague Jon, Töpel Thoralf, Ullman-Cullere Mollie, Utsunomiya Joji, van Kranen Henk J, Vihinen Mauno, Webb Elizabeth, Weber Thomas K, Yeager Meredith, Yeom Young I, Yim Seon-Hee, Yoo Hyang-Sook
Division of Personalised Nutrition and Medicine, FDA/National Center for Toxicological Research, Jefferson, Arkansas 72079, USA.
Hum Mutat. 2009 Apr;30(4):496-510. doi: 10.1002/humu.20972.
The remarkable progress in characterizing the human genome sequence, exemplified by the Human Genome Project and the HapMap Consortium, has led to the perception that knowledge and the tools (e.g., microarrays) are sufficient for many if not most biomedical research efforts. A large amount of data from diverse studies proves this perception inaccurate at best, and at worst, an impediment for further efforts to characterize the variation in the human genome. Because variation in genotype and environment are the fundamental basis to understand phenotypic variability and heritability at the population level, identifying the range of human genetic variation is crucial to the development of personalized nutrition and medicine. The Human Variome Project (HVP; http://www.humanvariomeproject.org/) was proposed initially to systematically collect mutations that cause human disease and create a cyber infrastructure to link locus specific databases (LSDB). We report here the discussions and recommendations from the 2008 HVP planning meeting held in San Feliu de Guixols, Spain, in May 2008.
以人类基因组计划和国际人类基因组单体型图计划为代表,在人类基因组序列特征研究方面取得的显著进展,使人们认为知识和工具(如微阵列)对于许多甚至大多数生物医学研究工作而言已经足够。来自各种研究的大量数据证明,这种看法往好里说是不准确的,往坏里说则是进一步了解人类基因组变异的障碍。由于基因型和环境的变异是在群体水平上理解表型变异性和遗传力的根本基础,确定人类遗传变异的范围对于个性化营养和医学的发展至关重要。人类变异组计划(HVP;http://www.humanvariomeproject.org/)最初旨在系统收集导致人类疾病的突变,并创建一个网络基础设施来链接特定基因座数据库(LSDB)。我们在此报告2008年5月在西班牙吉乔尔斯的圣费利乌举行的HVP规划会议的讨论情况和建议。